Relay Therapeutics Inc RLAY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:39 AM EDT
6.00quote price arrow up+0.04 (+0.76%)
Volume
11,818
52 week range
5.78 - 13.32
Loading...
  • Open5.97
  • Day High6.00
  • Day Low5.86
  • Prev Close5.95
  • 52 Week High13.32
  • 52 Week High Date07/12/23
  • 52 Week Low5.78
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap786.418M
  • Shares Out131.18M
  • 10 Day Average Volume1.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • YTD % Change-45.96

KEY STATS

  • Open5.97
  • Day High6.00
  • Day Low5.86
  • Prev Close5.95
  • 52 Week High13.32
  • 52 Week High Date07/12/23
  • 52 Week Low5.78
  • 52 Week Low Date04/22/24
  • Market Cap786.418M
  • Shares Out131.18M
  • 10 Day Average Volume1.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • YTD % Change-45.96

RATIOS/PROFITABILITY

  • EPS (TTM)-2.79
  • P/E (TTM)-2.15
  • Fwd P/E (NTM)-2.07
  • EBITDA (TTM)-367.70M
  • ROE (TTM)-40.18%
  • Revenue (TTM)25.546M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,338.66%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Relay Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The Company’s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and...
Alexis Borisy
Independent Chairman of the Board
Sanjiv Patel M.D.
President, Chief Executive Officer, Director
Thomas Catinazzo
Chief Financial Officer
Address
399 Binney Street, 2Nd Floor
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
ETNB
89Bio Inc
9.33+0.02+0.21%
CATX
Perspective Therapeutics Inc
1.57+0.04+2.61%
ZNTL
Zentalis Pharmaceuticals Inc
13.10+0.10+0.77%
IMTX
Immatics NV
10.25+0.06+0.59%
AUTL
Autolus Therapeutics PLC
4.62+0.06+1.32%